Your session is about to expire
← Back to Search
Intraocular Lens
Hoya AF-1 IOL for Cataract
Phase 4
Waitlist Available
Research Sponsored by Innovative Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
Study Summary
The doctors participating in this study are looking to show improved vision with the HOYA AF-1 aspheric intraocular lens after cataract surgery. They will also study the use of Revital Vision (neuro-sensory testing) in providing the highest potential for improved vision.
Eligible Conditions
- Cataract
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Measuring Ocular Dominance
Overall post surgical outcomes
Secondary outcome measures
Measuring visual acuities
Trial Design
2Treatment groups
Experimental Treatment
Group I: Revital VisionExperimental Treatment1 Intervention
Group II: Hoya AF-1 IOLExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
Innovative MedicalLead Sponsor
51 Previous Clinical Trials
2,608 Total Patients Enrolled
14 Trials studying Cataract
572 Patients Enrolled for Cataract
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger